Profile | GDS5420 / 243132_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 182.71 | 51 |
GSM1296119 | B_lesional_pre-dose | 48.69 | 28 |
GSM1296076 | C_lesional_pre-dose | 74.17 | 37 |
GSM1296092 | D_lesional_pre-dose | 50.03 | 33 |
GSM1296103 | E_lesional_pre-dose | 225.91 | 55 |
GSM1296078 | F_lesional_pre-dose | 55.41 | 33 |
GSM1296107 | G_lesional_pre-dose | 114.97 | 42 |
GSM1296109 | H_lesional_pre-dose | 212.19 | 52 |
GSM1296080 | I_lesional_pre-dose | 110.02 | 45 |
GSM1296090 | J_lesional_pre-dose | 38.79 | 28 |
GSM1296074 | K_lesional_pre-dose | 67.7 | 38 |
GSM1296111 | L_lesional_pre-dose | 102.6 | 40 |
GSM1296099 | M_lesional_pre-dose | 145.88 | 47 |
GSM1296086 | O_lesional_pre-dose | 44.92 | 30 |
GSM1296117 | P_lesional_pre-dose | 127.22 | 43 |
GSM1296113 | Q_lesional_pre-dose | 137.92 | 43 |
GSM1296096 | R_lesional_pre-dose | 86.16 | 40 |
GSM1296105 | S_lesional_pre-dose | 158.87 | 48 |
GSM1296098 | T_lesional_pre-dose | 399.71 | 64 |
GSM1296101 | U_lesional_pre-dose | 149.54 | 47 |
GSM1296121 | V_lesional_pre-dose | 75.79 | 36 |
GSM1296088 | W_lesional_pre-dose | 41.09 | 29 |
GSM1296082 | X_lesional_pre-dose | 37.87 | 28 |
GSM1296115 | Y_lesional_pre-dose | 135.27 | 45 |
GSM1296084 | Z_lesional_pre-dose | 126.58 | 45 |
GSM1296072 | B_lesional_day8 | 54.96 | 30 |
GSM1296069 | L_lesional_day8 | 160.62 | 46 |
GSM1296071 | P_lesional_day8 | 167.18 | 47 |
GSM1296070 | Y_lesional_day8 | 105.07 | 39 |
GSM1296073 | V_lesional_day8 | 64.84 | 34 |
GSM1296034 | A_lesional_day15 | 463.04 | 65 |
GSM1296041 | G_lesional_day15 | 111.67 | 42 |
GSM1296035 | R_lesional_day15 | 113.06 | 44 |
GSM1296038 | U_lesional_day15 | 136.53 | 46 |
GSM1296047 | B_lesional_day15 | 61.43 | 31 |
GSM1296039 | E_lesional_day15 | 104.64 | 42 |
GSM1296042 | H_lesional_day15 | 100.12 | 39 |
GSM1296043 | L_lesional_day15 | 102.23 | 39 |
GSM1296037 | M_lesional_day15 | 163.89 | 48 |
GSM1296046 | P_lesional_day15 | 177.37 | 48 |
GSM1296044 | Q_lesional_day15 | 151.89 | 46 |
GSM1296045 | Y_lesional_day15 | 121.84 | 41 |
GSM1296025 | C_lesional_day15 | 200.66 | 53 |
GSM1296033 | D_lesional_day15 | 21.07 | 19 |
GSM1296027 | I_lesional_day15 | 45.91 | 32 |
GSM1296032 | J_lesional_day15 | 97.97 | 41 |
GSM1296024 | K_lesional_day15 | 239.75 | 56 |
GSM1296031 | W_lesional_day15 | 164.46 | 48 |
GSM1296028 | X_lesional_day15 | 44.73 | 30 |
GSM1296029 | Z_lesional_day15 | 210.44 | 53 |
GSM1296026 | F_lesional_day15 | 125.52 | 46 |
GSM1296030 | O_lesional_day15 | 34.81 | 29 |
GSM1296040 | S_lesional_day15 | 223.54 | 54 |
GSM1296036 | T_lesional_day15 | 397.16 | 63 |
GSM1296048 | V_lesional_day15 | 80.63 | 37 |
GSM1296059 | A_lesional_day43 | 182.5 | 51 |
GSM1296066 | G_lesional_day43 | 114.12 | 41 |
GSM1296060 | R_lesional_day43 | 90.59 | 40 |
GSM1296063 | U_lesional_day43 | 91.74 | 39 |
GSM1296064 | E_lesional_day43 | 92.11 | 41 |
GSM1296067 | H_lesional_day43 | 136.04 | 44 |
GSM1296062 | M_lesional_day43 | 305.1 | 59 |
GSM1296068 | Q_lesional_day43 | 102.29 | 38 |
GSM1296050 | C_lesional_day43 | 35.72 | 25 |
GSM1296057 | D_lesional_day43 | 78.71 | 38 |
GSM1296052 | I_lesional_day43 | 57.26 | 35 |
GSM1296054 | J_lesional_day43 | 104.6 | 41 |
GSM1296049 | K_lesional_day43 | 129.95 | 46 |
GSM1296055 | W_lesional_day43 | 106.31 | 41 |
GSM1296053 | X_lesional_day43 | 49.4 | 31 |
GSM1296058 | Z_lesional_day43 | 61.78 | 35 |
GSM1296051 | F_lesional_day43 | 71.1 | 37 |
GSM1296056 | O_lesional_day43 | 30.66 | 25 |
GSM1296065 | S_lesional_day43 | 110.61 | 43 |
GSM1296061 | T_lesional_day43 | 453.32 | 65 |
GSM1296095 | A_non-lesional_pre-dose | 100.46 | 42 |
GSM1296120 | B_non-lesional_pre-dose | 70.53 | 33 |
GSM1296077 | C_non-lesional_pre-dose | 164.96 | 50 |
GSM1296093 | D_non-lesional_pre-dose | 163.79 | 48 |
GSM1296104 | E_non-lesional_pre-dose | 125.22 | 45 |
GSM1296079 | F_non-lesional_pre-dose | 133.95 | 47 |
GSM1296108 | G_non-lesional_pre-dose | 152.91 | 47 |
GSM1296110 | H_non-lesional_pre-dose | 251.31 | 54 |
GSM1296081 | I_non-lesional_pre-dose | 158.92 | 50 |
GSM1296091 | J_non-lesional_pre-dose | 73.13 | 37 |
GSM1296075 | K_non-lesional_pre-dose | 106.74 | 44 |
GSM1296112 | L_non-lesional_pre-dose | 128.08 | 42 |
GSM1296100 | M_non-lesional_pre-dose | 246.74 | 55 |
GSM1296087 | O_non-lesional_pre-dose | 39.24 | 29 |
GSM1296118 | P_non-lesional_pre-dose | 192.16 | 50 |
GSM1296114 | Q_non-lesional_pre-dose | 175.59 | 48 |
GSM1296097 | R_non-lesional_pre-dose | 100.71 | 41 |
GSM1296106 | S_non-lesional_pre-dose | 118.67 | 43 |
GSM1296102 | U_non-lesional_pre-dose | 268.17 | 56 |
GSM1296122 | V_non-lesional_pre-dose | 111.37 | 41 |
GSM1296089 | W_non-lesional_pre-dose | 61.8 | 33 |
GSM1296083 | X_non-lesional_pre-dose | 155.66 | 48 |
GSM1296116 | Y_non-lesional_pre-dose | 190.08 | 49 |
GSM1296085 | Z_non-lesional_pre-dose | 165.02 | 49 |